| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Forte Biosciences, Inc. (FBRX) has 8 insiders with recent SEC Form 4 filings, including 3 buys and 0 sells. FBRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 500.0K | $8.93M | - | |
| CFO | 22.0K | $392.7K | - | |
| Dir | 18.4K | $327.6K | - | |
| Dir | 18.4K | $327.6K | - | |
| Dir | 18.4K | $327.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 19, 2017 | Foletta Mark G72 | EVP &Chief Financial Officer | Buy | 5,000 | $10.00 | $50,000.00 | New | |
| Apr 19, 2017 | Gruber Harry E | President, Research &Devel | Buy | 25,000 | $10.00 | $250,000.00 | +6.4% | |
| Apr 19, 2017 | Hasnain Faheem74 | Director | Buy | 100,000 | $10.00 | $1,000,000.00 | +97.2% |